Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Dual vs Half-dose Quadruple Therapy for H. pylori in Elderly
NCT04101708Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Sep 2019
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lansoprazole, amoxicillin in Helicobacter pylori infection, sponsored by Shandong University. Status: unknown.
02
Drugs
lansoprazoleamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04101708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04101708.